ATI PN PHARMACOLOGY PROCTORED EXAM V10 2026/2027 - 400 VERIFIED QUESTIONS WITH
MIXED ANSWERS A,B,C,D & RATIONALES | A+ GRADED - NO REPEAT
Course: ATI PN Pharmacology Proctored V10 2026/2027 | 400Q Mixed A/B/C/D: A=100 B=103 C=98 D=99 | 2026/2027 - No
Repeat Edition
9 new versions - 100% unique questions - no repeat from previous PN Pharm file. Original 2026/2027 content, mixed keys.
1. [V10] Levothyroxine teaching? - Case 1 PN Pharm 2026/2027
A. Take with iron
B. Take 30-60 min before breakfast on empty stomach, same time daily
C. Take with milk
D. Take with food, at night
Answer: B
Rationale: Levo empty stomach, no soy, iron, calcium within 4h. - Version 10 2026/2027
2. [V10] Glargine (Lantus) rule? - Case 2 PN Pharm 2026/2027
A. Mix with regular
B. IV push
C. Do not mix, given at same time daily, no peak - basal insulin
D. Give with meals only
Answer: C
Rationale: Glargine long-acting no mix, basal. - Version 10 2026/2027
3. [V10] Vancomycin infusion reaction red man? - Case 3 PN Pharm 2026/2027
A. No action
B. Give fast
C. Stop forever
D. Infuse slowly over 60-90 min, antihistamine, not allergy
Answer: D
Rationale: Red man from fast infusion - slow infusion. - Version 10 2026/2027
4. [V10] PN role in blood transfusion? - Case 4 PN Pharm 2026/2027
A. Monitor transfusion, vitals q15min, stop if reaction, notify RN/provider
B. Start transfusion
C. Crossmatch
D. Order blood
Answer: A
Rationale: PN monitors transfusion, stops if reaction. - Version 10 2026/2027
5. [V10] Bisacodyl use? - Case 5 PN Pharm 2026/2027
A. Fever
B. Constipation - stimulant laxative
C. Diarrhea
D. Pain
Answer: B
Rationale: Stimulant laxative. - Version 10 2026/2027
6. [V10] Levodopa-carbidopa teaching? - Case 6 PN Pharm 2026/2027
A. Take with milk only
B. Take with high protein
C. Take low protein, avoid high protein reduces absorption, dark sweat/urine normal
D. No teaching
Answer: C
Rationale: Levodopa low protein diet. - Version 10 2026/2027
7. [V10] Potassium chloride administration? - Case 7 PN Pharm 2026/2027
A. No monitor
B. IV push
C. Never IV push - dilute, give via pump, check kidney function, monitor EKG
D. Give fast
Answer: C
Rationale: KCl never IV push, dilute. - Version 10 2026/2027
8. [V10] Ondansetron use? - Case 8 PN Pharm 2026/2027
A. Diarrhea
B. Pain
C. Fever
, D. Nausea/vomiting - monitor QT, headache, constipation
Answer: D
Rationale: Zofran antiemetic QT risk. - Version 10 2026/2027
9. [V10] Albuterol side effects? - Case 9 PN Pharm 2026/2027
A. Bradycardia
B. Tachycardia, tremor, nervousness - beta2 agonist
C. Cough always
D. Weight gain
Answer: B
Rationale: Albuterol tachycardia, tremor. - Version 10 2026/2027
10. [V10] Montelukast when to take? - Case 10 PN Pharm 2026/2027
A. Evening - asthma prophylaxis, not rescue
B. Morning only
C. During attack only
D. No timing
Answer: A
Rationale: Montelukast evening daily, not rescue. - Version 10 2026/2027
11. [V10] Psyllium teaching? - Case 11 PN Pharm 2026/2027
A. Take dry
B. No water
C. Take with full glass water, may cause bloating, fiber
D. At bedtime only
Answer: C
Rationale: Psyllium needs water. - Version 10 2026/2027
12. [V10] Atropine use? - Case 12 PN Pharm 2026/2027
A. Bradycardia symptomatic, organophosphate poisoning antidote
B. Tachycardia
C. No use
D. Hypertension
Answer: A
Rationale: Atropine increases HR in symptomatic bradycardia. - Version 10 2026/2027
13. [V10] Haloperidol EPS treatment? - Case 13 PN Pharm 2026/2027
A. Benztropine/diphenhydramine for acute dystonia, monitor EPS
B. No monitor
C. No treatment
D. Stop water
Answer: A
Rationale: Antipsychotic EPS benztropine. - Version 10 2026/2027
14. [V10] Warfarin antidote for bleeding? - Case 14 PN Pharm 2026/2027
A. Vitamin K + 4F-PCC for life-threatening
B. Protamine
C. Naloxone
D. Calcium
Answer: A
Rationale: Vitamin K for warfarin reversal, PCC for severe bleed. - Version 10 2026/2027
15. [V10] LPN cannot do IV push - Case 15 PN Pharm 2026/2027
A. Can do IV push
B. Can do all
C. LPN cannot do IV push meds, initial assessment, teaching, unstable clients
D. Can do assessment
Answer: C
Rationale: LPN scope no IV push, no initial assessment. - Version 10 2026/2027
16. [V10] Amoxicillin allergic reaction first? - Case 16 PN Pharm 2026/2027
A. Double dose
B. Stop drug, notify provider, assess airway - anaphylaxis risk
C. Give next dose
D. Take with milk
Answer: B
Rationale: Penicillin allergy stop drug, airway assessment. - Version 10 2026/2027
17. [V10] Phenytoin teaching? - Case 17 PN Pharm 2026/2027
, A. No hygiene
B. Good oral hygiene, avoid alcohol, therapeutic 10-20 mcg/mL, gum hyperplasia risk
C. Skip doses
D. Double dose if missed
Answer: B
Rationale: Phenytoin gum hyperplasia, hygiene. - Version 10 2026/2027
18. [V10] Loperamide use? - Case 18 PN Pharm 2026/2027
A. Fever
B. Constipation
C. Diarrhea - anti-diarrheal, monitor fluid/electrolytes
D. Pain
Answer: C
Rationale: Loperamide anti-diarrheal. - Version 10 2026/2027
19. [V10] Metformin and contrast dye - why hold? - Case 19 PN Pharm 2026/2027
A. Causes hyperglycemia
B. Risk lactic acidosis if contrast-induced AKI - hold 48h before/after per protocol
C. No reason
D. Causes HTN
Answer: B
Rationale: Hold metformin before contrast to prevent lactic acidosis with AKI. - Version 10 2026/2027
20. [V10] A client taking amlodipine reports ankle swelling. Best response? - Case 20 PN Pharm 2026/2027
A. Stop drug immediately
B. Take double dose
C. No action
D. Ankle swelling common with amlodipine - elevate legs, notify provider if worsens, monitor BP
Answer: D
Rationale: CCB amlodipine causes peripheral edema - elevate legs, monitor. - Version 10 2026/2027
21. [V10] NPH insulin appearance? - Case 21 PN Pharm 2026/2027
A. Clear yellow
B. No appearance
C. Cloudy - must roll not shake, 30 min to 1h onset, peak 4-12h
D. Clear
Answer: C
Rationale: NPH cloudy intermediate. - Version 10 2026/2027
22. [V10] Digoxin antidote? - Case 22 PN Pharm 2026/2027
A. Digoxin immune Fab (Digibind)
B. Vitamin K
C. Protamine
D. Naloxone
Answer: A
Rationale: Digibind binds digoxin in toxicity. - Version 10 2026/2027
23. [V10] Heparin antidote? - Case 23 PN Pharm 2026/2027
A. Protamine sulfate
B. Naloxone
C. Flumazenil
D. Vitamin K
Answer: A
Rationale: Protamine binds heparin. - Version 10 2026/2027
24. [V10] Prednisone long-term side effects? - Case 24 PN Pharm 2026/2027
A. Weight loss
B. No effects
C. Hypoglycemia
D. Weight gain, hyperglycemia, moon face, buffalo hump, osteoporosis, infection risk
Answer: D
Rationale: Steroids cause Cushingoid appearance, hyperglycemia, osteoporosis. - Version 10 2026/2027
25. [V10] Ipratropium (Atrovent) teaching? - Case 25 PN Pharm 2026/2027
A. No rinse
B. Avoid if peanut allergy - contains soy lecithin, rinse mouth
C. Take with food
D. No teaching
, Answer: B
Rationale: Ipratropium caution peanut/soy allergy, rinse mouth. - Version 10 2026/2027
26. [V10] Lithium therapeutic level? - Case 26 PN Pharm 2026/2027
A. 0.6-1.2 mEq/L, toxicity >1.5 - monitor kidney, thyroid, hydration
B. 5.0
C. 0.1
D. 10
Answer: A
Rationale: Lithium narrow therapeutic, monitor. - Version 10 2026/2027
27. [V10] Benzodiazepine overdose antidote? - Case 27 PN Pharm 2026/2027
A. Protamine
B. Vitamin K
C. Flumazenil
D. Naloxone
Answer: C
Rationale: Flumazenil reverses benzos, risk seizures. - Version 10 2026/2027
28. [V10] Insulin lispro onset? - Case 28 PN Pharm 2026/2027
A. 15 minutes rapid-acting, peak 1-2h, duration 3-4h
B. 2 hours
C. 6 hours
D. 12 hours
Answer: A
Rationale: Lispro rapid 15 min onset. - Version 10 2026/2027
29. [V10] Carbamazepine side effect? - Case 29 PN Pharm 2026/2027
A. Weight loss only
B. No monitoring
C. No effects
D. Blood dyscrasias, check CBC, rash SJS risk, avoid grapefruit
Answer: D
Rationale: Carbamazepine CBC, rash. - Version 10 2026/2027
30. [V10] Lisinopril causes dry cough due to? - Case 30 PN Pharm 2026/2027
A. K+ loss
B. Na retention
C. Bradykinin accumulation in lungs - ACE inhibitor side effect
D. Histamine
Answer: C
Rationale: ACE cough from bradykinin. Switch to ARB if intolerable. - Version 10 2026/2027
31. [V10] Opioid overdose antidote? - Case 31 PN Pharm 2026/2027
A. Flumazenil
B. Naloxone - may need repeat due to short half-life
C. Vitamin K
D. Protamine
Answer: B
Rationale: Naloxone opioid antagonist, monitor for re-sedation. - Version 10 2026/2027
32. [V10] Hypoglycemia treatment conscious PN? - Case 32 PN Pharm 2026/2027
A. No treatment
B. Give insulin
C. 15g fast carb juice/glucose tabs, recheck 15 min, repeat if <70
D. Water
Answer: C
Rationale: Rule of 15 for hypo. - Version 10 2026/2027
33. [V10] Epinephrine use in anaphylaxis? - Case 33 PN Pharm 2026/2027
A. No use
B. Anaphylaxis first-line - IM in mid-thigh, bronchodilation, vasoconstriction
C. Bradycardia only
D. Hypotension only
Answer: B
Rationale: Epi first in anaphylaxis IM. - Version 10 2026/2027
34. [V10] Ciprofloxacin teaching? - Case 34 PN Pharm 2026/2027
A. Avoid antacids, iron, dairy within 2h, drink fluids, avoid sun - tendon rupture risk
MIXED ANSWERS A,B,C,D & RATIONALES | A+ GRADED - NO REPEAT
Course: ATI PN Pharmacology Proctored V10 2026/2027 | 400Q Mixed A/B/C/D: A=100 B=103 C=98 D=99 | 2026/2027 - No
Repeat Edition
9 new versions - 100% unique questions - no repeat from previous PN Pharm file. Original 2026/2027 content, mixed keys.
1. [V10] Levothyroxine teaching? - Case 1 PN Pharm 2026/2027
A. Take with iron
B. Take 30-60 min before breakfast on empty stomach, same time daily
C. Take with milk
D. Take with food, at night
Answer: B
Rationale: Levo empty stomach, no soy, iron, calcium within 4h. - Version 10 2026/2027
2. [V10] Glargine (Lantus) rule? - Case 2 PN Pharm 2026/2027
A. Mix with regular
B. IV push
C. Do not mix, given at same time daily, no peak - basal insulin
D. Give with meals only
Answer: C
Rationale: Glargine long-acting no mix, basal. - Version 10 2026/2027
3. [V10] Vancomycin infusion reaction red man? - Case 3 PN Pharm 2026/2027
A. No action
B. Give fast
C. Stop forever
D. Infuse slowly over 60-90 min, antihistamine, not allergy
Answer: D
Rationale: Red man from fast infusion - slow infusion. - Version 10 2026/2027
4. [V10] PN role in blood transfusion? - Case 4 PN Pharm 2026/2027
A. Monitor transfusion, vitals q15min, stop if reaction, notify RN/provider
B. Start transfusion
C. Crossmatch
D. Order blood
Answer: A
Rationale: PN monitors transfusion, stops if reaction. - Version 10 2026/2027
5. [V10] Bisacodyl use? - Case 5 PN Pharm 2026/2027
A. Fever
B. Constipation - stimulant laxative
C. Diarrhea
D. Pain
Answer: B
Rationale: Stimulant laxative. - Version 10 2026/2027
6. [V10] Levodopa-carbidopa teaching? - Case 6 PN Pharm 2026/2027
A. Take with milk only
B. Take with high protein
C. Take low protein, avoid high protein reduces absorption, dark sweat/urine normal
D. No teaching
Answer: C
Rationale: Levodopa low protein diet. - Version 10 2026/2027
7. [V10] Potassium chloride administration? - Case 7 PN Pharm 2026/2027
A. No monitor
B. IV push
C. Never IV push - dilute, give via pump, check kidney function, monitor EKG
D. Give fast
Answer: C
Rationale: KCl never IV push, dilute. - Version 10 2026/2027
8. [V10] Ondansetron use? - Case 8 PN Pharm 2026/2027
A. Diarrhea
B. Pain
C. Fever
, D. Nausea/vomiting - monitor QT, headache, constipation
Answer: D
Rationale: Zofran antiemetic QT risk. - Version 10 2026/2027
9. [V10] Albuterol side effects? - Case 9 PN Pharm 2026/2027
A. Bradycardia
B. Tachycardia, tremor, nervousness - beta2 agonist
C. Cough always
D. Weight gain
Answer: B
Rationale: Albuterol tachycardia, tremor. - Version 10 2026/2027
10. [V10] Montelukast when to take? - Case 10 PN Pharm 2026/2027
A. Evening - asthma prophylaxis, not rescue
B. Morning only
C. During attack only
D. No timing
Answer: A
Rationale: Montelukast evening daily, not rescue. - Version 10 2026/2027
11. [V10] Psyllium teaching? - Case 11 PN Pharm 2026/2027
A. Take dry
B. No water
C. Take with full glass water, may cause bloating, fiber
D. At bedtime only
Answer: C
Rationale: Psyllium needs water. - Version 10 2026/2027
12. [V10] Atropine use? - Case 12 PN Pharm 2026/2027
A. Bradycardia symptomatic, organophosphate poisoning antidote
B. Tachycardia
C. No use
D. Hypertension
Answer: A
Rationale: Atropine increases HR in symptomatic bradycardia. - Version 10 2026/2027
13. [V10] Haloperidol EPS treatment? - Case 13 PN Pharm 2026/2027
A. Benztropine/diphenhydramine for acute dystonia, monitor EPS
B. No monitor
C. No treatment
D. Stop water
Answer: A
Rationale: Antipsychotic EPS benztropine. - Version 10 2026/2027
14. [V10] Warfarin antidote for bleeding? - Case 14 PN Pharm 2026/2027
A. Vitamin K + 4F-PCC for life-threatening
B. Protamine
C. Naloxone
D. Calcium
Answer: A
Rationale: Vitamin K for warfarin reversal, PCC for severe bleed. - Version 10 2026/2027
15. [V10] LPN cannot do IV push - Case 15 PN Pharm 2026/2027
A. Can do IV push
B. Can do all
C. LPN cannot do IV push meds, initial assessment, teaching, unstable clients
D. Can do assessment
Answer: C
Rationale: LPN scope no IV push, no initial assessment. - Version 10 2026/2027
16. [V10] Amoxicillin allergic reaction first? - Case 16 PN Pharm 2026/2027
A. Double dose
B. Stop drug, notify provider, assess airway - anaphylaxis risk
C. Give next dose
D. Take with milk
Answer: B
Rationale: Penicillin allergy stop drug, airway assessment. - Version 10 2026/2027
17. [V10] Phenytoin teaching? - Case 17 PN Pharm 2026/2027
, A. No hygiene
B. Good oral hygiene, avoid alcohol, therapeutic 10-20 mcg/mL, gum hyperplasia risk
C. Skip doses
D. Double dose if missed
Answer: B
Rationale: Phenytoin gum hyperplasia, hygiene. - Version 10 2026/2027
18. [V10] Loperamide use? - Case 18 PN Pharm 2026/2027
A. Fever
B. Constipation
C. Diarrhea - anti-diarrheal, monitor fluid/electrolytes
D. Pain
Answer: C
Rationale: Loperamide anti-diarrheal. - Version 10 2026/2027
19. [V10] Metformin and contrast dye - why hold? - Case 19 PN Pharm 2026/2027
A. Causes hyperglycemia
B. Risk lactic acidosis if contrast-induced AKI - hold 48h before/after per protocol
C. No reason
D. Causes HTN
Answer: B
Rationale: Hold metformin before contrast to prevent lactic acidosis with AKI. - Version 10 2026/2027
20. [V10] A client taking amlodipine reports ankle swelling. Best response? - Case 20 PN Pharm 2026/2027
A. Stop drug immediately
B. Take double dose
C. No action
D. Ankle swelling common with amlodipine - elevate legs, notify provider if worsens, monitor BP
Answer: D
Rationale: CCB amlodipine causes peripheral edema - elevate legs, monitor. - Version 10 2026/2027
21. [V10] NPH insulin appearance? - Case 21 PN Pharm 2026/2027
A. Clear yellow
B. No appearance
C. Cloudy - must roll not shake, 30 min to 1h onset, peak 4-12h
D. Clear
Answer: C
Rationale: NPH cloudy intermediate. - Version 10 2026/2027
22. [V10] Digoxin antidote? - Case 22 PN Pharm 2026/2027
A. Digoxin immune Fab (Digibind)
B. Vitamin K
C. Protamine
D. Naloxone
Answer: A
Rationale: Digibind binds digoxin in toxicity. - Version 10 2026/2027
23. [V10] Heparin antidote? - Case 23 PN Pharm 2026/2027
A. Protamine sulfate
B. Naloxone
C. Flumazenil
D. Vitamin K
Answer: A
Rationale: Protamine binds heparin. - Version 10 2026/2027
24. [V10] Prednisone long-term side effects? - Case 24 PN Pharm 2026/2027
A. Weight loss
B. No effects
C. Hypoglycemia
D. Weight gain, hyperglycemia, moon face, buffalo hump, osteoporosis, infection risk
Answer: D
Rationale: Steroids cause Cushingoid appearance, hyperglycemia, osteoporosis. - Version 10 2026/2027
25. [V10] Ipratropium (Atrovent) teaching? - Case 25 PN Pharm 2026/2027
A. No rinse
B. Avoid if peanut allergy - contains soy lecithin, rinse mouth
C. Take with food
D. No teaching
, Answer: B
Rationale: Ipratropium caution peanut/soy allergy, rinse mouth. - Version 10 2026/2027
26. [V10] Lithium therapeutic level? - Case 26 PN Pharm 2026/2027
A. 0.6-1.2 mEq/L, toxicity >1.5 - monitor kidney, thyroid, hydration
B. 5.0
C. 0.1
D. 10
Answer: A
Rationale: Lithium narrow therapeutic, monitor. - Version 10 2026/2027
27. [V10] Benzodiazepine overdose antidote? - Case 27 PN Pharm 2026/2027
A. Protamine
B. Vitamin K
C. Flumazenil
D. Naloxone
Answer: C
Rationale: Flumazenil reverses benzos, risk seizures. - Version 10 2026/2027
28. [V10] Insulin lispro onset? - Case 28 PN Pharm 2026/2027
A. 15 minutes rapid-acting, peak 1-2h, duration 3-4h
B. 2 hours
C. 6 hours
D. 12 hours
Answer: A
Rationale: Lispro rapid 15 min onset. - Version 10 2026/2027
29. [V10] Carbamazepine side effect? - Case 29 PN Pharm 2026/2027
A. Weight loss only
B. No monitoring
C. No effects
D. Blood dyscrasias, check CBC, rash SJS risk, avoid grapefruit
Answer: D
Rationale: Carbamazepine CBC, rash. - Version 10 2026/2027
30. [V10] Lisinopril causes dry cough due to? - Case 30 PN Pharm 2026/2027
A. K+ loss
B. Na retention
C. Bradykinin accumulation in lungs - ACE inhibitor side effect
D. Histamine
Answer: C
Rationale: ACE cough from bradykinin. Switch to ARB if intolerable. - Version 10 2026/2027
31. [V10] Opioid overdose antidote? - Case 31 PN Pharm 2026/2027
A. Flumazenil
B. Naloxone - may need repeat due to short half-life
C. Vitamin K
D. Protamine
Answer: B
Rationale: Naloxone opioid antagonist, monitor for re-sedation. - Version 10 2026/2027
32. [V10] Hypoglycemia treatment conscious PN? - Case 32 PN Pharm 2026/2027
A. No treatment
B. Give insulin
C. 15g fast carb juice/glucose tabs, recheck 15 min, repeat if <70
D. Water
Answer: C
Rationale: Rule of 15 for hypo. - Version 10 2026/2027
33. [V10] Epinephrine use in anaphylaxis? - Case 33 PN Pharm 2026/2027
A. No use
B. Anaphylaxis first-line - IM in mid-thigh, bronchodilation, vasoconstriction
C. Bradycardia only
D. Hypotension only
Answer: B
Rationale: Epi first in anaphylaxis IM. - Version 10 2026/2027
34. [V10] Ciprofloxacin teaching? - Case 34 PN Pharm 2026/2027
A. Avoid antacids, iron, dairy within 2h, drink fluids, avoid sun - tendon rupture risk
